Mustafa Solak, M.D. is a medical doctor who graduated from Hacettepe University School of Medicine and has completed residencies at Istanbul Sisli Etfal Teaching and Research Hospital and a fellowship at Hacettepe University Cancer Institute. He specializes in Breast Cancer, Testicular Cancer, Ovarian Cancer, Lung Cancer, Head-Neck Cancer, and Gastrointestinal Cancers. He has also worked at the University of Texas MD Anderson Cancer Center, Hitit University Corum Training Hospital, and Medical Park Hospital.
Read moreMustafa Solak, M.D. is a medical doctor who graduated from Hacettepe University School of Medicine and has completed residencies at Istanbul Sisli Etfal Teaching and Research Hospital and a fellowship at Hacettepe University Cancer Institute. He specializes in Breast Cancer, Testicular Cancer, Ovarian Cancer, Lung Cancer, Head-Neck Cancer, and Gastrointestinal Cancers. He has also worked at the University of Texas MD Anderson Cancer Center, Hitit University Corum Training Hospital, and Medical Park Hospital.
| Doctor's visit | price on request |
| Whipple surgery | $14500 - $15000 |
| Chemotherapy | $1500 - $2500 |
| Thyroid resection | $5000 - $7500 |
| Doctor's visit | price on request |
| Whipple surgery | $14500 - $15000 |
| Chemotherapy | $1500 - $2500 |
| Thyroid resection | $5000 - $7500 |
orchiopexy in cryptorchidism: a single centre experience with long-term follow-up. PEDIATRIC SURGERY INTERNATIONAL, 18 : 140-141, 2002
Uygur MC, Tan MO, Ünal D, Erol D: The outcome of one-stage repair of proximal hypospadias with wide ventral preputial island flap. PEDIATRIC SURGERY INTERNATIONAL, 18: 139-140, 2002
Dr. Uygur is an international urologist with a Medical Graduate and M.D. Degree from Hacettepe University Medical School, a research fellowship from the Transplantation Laboratory of Helsinki University, and residency in Urology from Hacettepe University Medical School. He has over 300 international and national publications and presentations, with 781 scientific citations to 41 articles. He is a full member of the European Association of Urology, a corresponding member of the American Urological Association, a member of the Society of Urologic Oncology, and a board member of the Turkish Society of Urologic Oncology. He has completed robotic urologic surgery courses at Vanderbilt University Hospital, the Cleveland Clinic, and the USC Norris Comprehensive Cancer Center. He is the Professor of Urology and Chair at the Near East University Medical School, the Chief of Urology at the Anadolu Medical Center in Affiliation with Johns Hopkins Medicine, and the Director of Urooncology and Urologic Robotic Surgery Programmes at the Anadolu Medical Center. He is also a scientific secretary of biannual Ankara Urooncology Courses, and has organized many national or regional Urology and Urooncology meetings.
Read moreorchiopexy in cryptorchidism: a single centre experience with long-term follow-up. PEDIATRIC SURGERY INTERNATIONAL, 18 : 140-141, 2002
Uygur MC, Tan MO, Ünal D, Erol D: The outcome of one-stage repair of proximal hypospadias with wide ventral preputial island flap. PEDIATRIC SURGERY INTERNATIONAL, 18: 139-140, 2002
Dr. Uygur is an international urologist with a Medical Graduate and M.D. Degree from Hacettepe University Medical School, a research fellowship from the Transplantation Laboratory of Helsinki University, and residency in Urology from Hacettepe University Medical School. He has over 300 international and national publications and presentations, with 781 scientific citations to 41 articles. He is a full member of the European Association of Urology, a corresponding member of the American Urological Association, a member of the Society of Urologic Oncology, and a board member of the Turkish Society of Urologic Oncology. He has completed robotic urologic surgery courses at Vanderbilt University Hospital, the Cleveland Clinic, and the USC Norris Comprehensive Cancer Center. He is the Professor of Urology and Chair at the Near East University Medical School, the Chief of Urology at the Anadolu Medical Center in Affiliation with Johns Hopkins Medicine, and the Director of Urooncology and Urologic Robotic Surgery Programmes at the Anadolu Medical Center. He is also a scientific secretary of biannual Ankara Urooncology Courses, and has organized many national or regional Urology and Urooncology meetings.
| Doctor's visit | price on request |
| Chemotherapy | $600 - $1800 |
| Mastectomy | $2500 - $6000 |
| Esophagectomy | $8000 - $10000 |
Dr. Sertkaya graduated from Konya Meram Science High School in 2001 and entered Gazi University Medical Faculty the same year, graduating in 2008. He completed his urology specialization at Haydarpaşa Numune Training and Research Hospital in 2014, becoming a urology specialist.
Since becoming a specialist, he has focused on the sub-branch of Andrology, attending various training sessions and conferences and performing surgeries with some of the world's leading Andrology professors. In 2017, he passed the written and oral proficiency exams conducted by the European Association of Urology, earning the title of "FEBU."
In 2020, Dr. Sertkaya achieved the rank of Associate Professor of Urology. His journey in Urology and Andrology, which began in 2008, continues at the Andro Expertise Male Health and Aesthetics Center, which he founded in 2022. He sees patients in his own clinic and performs surgeries at affiliated hospitals.
Read moreDr. Sertkaya graduated from Konya Meram Science High School in 2001 and entered Gazi University Medical Faculty the same year, graduating in 2008. He completed his urology specialization at Haydarpaşa Numune Training and Research Hospital in 2014, becoming a urology specialist.
Since becoming a specialist, he has focused on the sub-branch of Andrology, attending various training sessions and conferences and performing surgeries with some of the world's leading Andrology professors. In 2017, he passed the written and oral proficiency exams conducted by the European Association of Urology, earning the title of "FEBU."
In 2020, Dr. Sertkaya achieved the rank of Associate Professor of Urology. His journey in Urology and Andrology, which began in 2008, continues at the Andro Expertise Male Health and Aesthetics Center, which he founded in 2022. He sees patients in his own clinic and performs surgeries at affiliated hospitals.
2011 – 2015, (Internal Medicine Specialist) Istanbul University Istanbul School of Education and Career
Medicine Department of Internal Medicine
2015 – 2016, (Internal Medicine) Specialist Istanbul Haydarpasa Numune Training and Research Hospital
2016 – 2019, (Medical Oncology) Istanbul University Istanbul School of Medicine Department of Medical Oncology
2019 – 2021, (Medical Oncology Specialist) - Istanbul Haydarpasa Numune Training and Research Hospital
2021 – 2024, (Associate Professor) Marmara University School of Medicine Department of Medical Oncology
Memberships in Scientific Organizations
ASCO
ESMO
TTOD
AVOD
Publications
In the field of oncology, he has published over 30 peer-reviewed articles at both international and national levels.
Awards Received
EAACI The European Academy of Allergy and Clinical Immunology 2019 Best Poster Award
"The top 3rd verbal presentation, IGICC (11th International Gastrointestinal Cancers Conference – IGICC2021)"
Speeches Delivered at National Congresses, Conferences, and Symposia:
Courses, Meetings, and Certificates
ESMO certified Medical Oncologist since 2019
Read more
2011 – 2015, (Internal Medicine Specialist) Istanbul University Istanbul School of Education and Career
Medicine Department of Internal Medicine
2015 – 2016, (Internal Medicine) Specialist Istanbul Haydarpasa Numune Training and Research Hospital
2016 – 2019, (Medical Oncology) Istanbul University Istanbul School of Medicine Department of Medical Oncology
2019 – 2021, (Medical Oncology Specialist) - Istanbul Haydarpasa Numune Training and Research Hospital
2021 – 2024, (Associate Professor) Marmara University School of Medicine Department of Medical Oncology
Memberships in Scientific Organizations
ASCO
ESMO
TTOD
AVOD
Publications
In the field of oncology, he has published over 30 peer-reviewed articles at both international and national levels.
Awards Received
EAACI The European Academy of Allergy and Clinical Immunology 2019 Best Poster Award
"The top 3rd verbal presentation, IGICC (11th International Gastrointestinal Cancers Conference – IGICC2021)"
Speeches Delivered at National Congresses, Conferences, and Symposia:
Courses, Meetings, and Certificates
ESMO certified Medical Oncologist since 2019
Experience:
2022 -
Medipol Bahçelievler
2021 - 2022
MEDIPOL UNIVERSITY SEFAKÖY HOSPITAL
2018 - 2020
İSTİNYE UNIVERSITY FACULTY OF MEDICINE
2014 - 2020
TOKAT STATE HOSPITAL
2010 - 2010
BINGOL STATE HOSPITAL
Education:
2021
MEDIPOL UNIVERSITY, GASTROTEROLOGY
2018
İSTINYE UNIVERSITY, INTERNAL DISEASES USA
2014
ANKARA TRAINING AND RESEARCH HOSPITAL, GASTROENTEROLOGY
2010
FIRAT UNIVERSITY, FACULTY OF MEDICINE/INTERNAL MEDICAL SCIENCES DEPARTMENT/INTERNAL MEDICINE DEPARTMENT
2004
FIRAT UNIVERSITY, FACULTY OF MEDICINE
A. International Peer-Reviewed Journal Articles:
Title: Fatal fulminant hepatitis B after withdrawal of entecavir treatment in a patient with HBeAg seroconversion.
Title: Acute gastric obstruction resulting from gallstone-induced bezoar.
Title: Garlic-induced esophagitis.
Title: Association between Helicobacter pylori and liver-to-spleen ratio.
Title: Crohn's disease masked by median arcuate ligament syndrome.
Title: Telaprevir and anemia: What we learned from the first three patients.
Title: Magnesium and parathyroid hormone levels of patients using different proton pump inhibitors.
Title: Is topical pharyngeal anesthesia necessary in esophagogastroduodenoscopy in all unsedated patients?
Title: Inpatient Care Of Hepatitis C: Applying The Four Pillars Model To The Hospital Setting.
Title: "The "Bouveret's Syndrome" Case Resolved Without Necrotic Changes."
Title: Severe acute pancreatitis due to hypertriglyceridemia.
Title: Gallstone Ileus Caused by Cholecystoenteric Fistula Demonstrated on Computed Tomography.
Title: Intestinal Perforation Due to Ingested Chicken Bone Mimicking Crohn's Disease.
Title: Acute pancreatitis induced by hypertriglyceridemia: A case-based review.
Title: An Unusual Complication of Endoscopic Retrograde Cholangiopancreatography: Severe Acute Pancreatitis Leading to Death.
Title: A Rare Cause of Abdominal Pain: Mesenteric Panniculitis.
B. Contributions to Scientific Conferences:
Title: Suicidal poisonings in Turkey: demographic and clinical aspects.
Title: A Rare Cause of Gastrointestinal Bleeding: Aortoenteric Fistula.
Experience:
2022 -
Medipol Bahçelievler
2021 - 2022
MEDIPOL UNIVERSITY SEFAKÖY HOSPITAL
2018 - 2020
İSTİNYE UNIVERSITY FACULTY OF MEDICINE
2014 - 2020
TOKAT STATE HOSPITAL
2010 - 2010
BINGOL STATE HOSPITAL
Education:
2021
MEDIPOL UNIVERSITY, GASTROTEROLOGY
2018
İSTINYE UNIVERSITY, INTERNAL DISEASES USA
2014
ANKARA TRAINING AND RESEARCH HOSPITAL, GASTROENTEROLOGY
2010
FIRAT UNIVERSITY, FACULTY OF MEDICINE/INTERNAL MEDICAL SCIENCES DEPARTMENT/INTERNAL MEDICINE DEPARTMENT
2004
FIRAT UNIVERSITY, FACULTY OF MEDICINE
A. International Peer-Reviewed Journal Articles:
Title: Fatal fulminant hepatitis B after withdrawal of entecavir treatment in a patient with HBeAg seroconversion.
Title: Acute gastric obstruction resulting from gallstone-induced bezoar.
Title: Garlic-induced esophagitis.
Title: Association between Helicobacter pylori and liver-to-spleen ratio.
Title: Crohn's disease masked by median arcuate ligament syndrome.
Title: Telaprevir and anemia: What we learned from the first three patients.
Title: Magnesium and parathyroid hormone levels of patients using different proton pump inhibitors.
Title: Is topical pharyngeal anesthesia necessary in esophagogastroduodenoscopy in all unsedated patients?
Title: Inpatient Care Of Hepatitis C: Applying The Four Pillars Model To The Hospital Setting.
Title: "The "Bouveret's Syndrome" Case Resolved Without Necrotic Changes."
Title: Severe acute pancreatitis due to hypertriglyceridemia.
Title: Gallstone Ileus Caused by Cholecystoenteric Fistula Demonstrated on Computed Tomography.
Title: Intestinal Perforation Due to Ingested Chicken Bone Mimicking Crohn's Disease.
Title: Acute pancreatitis induced by hypertriglyceridemia: A case-based review.
Title: An Unusual Complication of Endoscopic Retrograde Cholangiopancreatography: Severe Acute Pancreatitis Leading to Death.
Title: A Rare Cause of Abdominal Pain: Mesenteric Panniculitis.
B. Contributions to Scientific Conferences:
Title: Suicidal poisonings in Turkey: demographic and clinical aspects.
Title: A Rare Cause of Gastrointestinal Bleeding: Aortoenteric Fistula.
| Doctor's visit | price on request |
| Radioiodine therapy | $5000 - $7000 |
| Radiation therapy for brain tumor | $4000 - $6000 |
| Mastectomy | $5000 - $7500 |
Assoc. Prof. Ali Eser received his medical education at Uludağ University Faculty of Medicine; He completed his internal medicine residency training at Istanbul Training and Research Hospital and his hematology residency training at Marmara University.
Afterward, he completed his compulsory service at Marmara University Hematology Clinic, firstly at Çanakkale University and then at Bezmialem Vakıf University. He served as a lecturer. After working as a hematology specialist and assistant physician in charge of the adult bone marrow transplant unit for 2 years at Hisar Intercontinental Hospital, he worked as a lecturer at Bezmialem Vakıf University and in the adult bone marrow transplant unit at Istanbul Yeniyüzyıl University, and finally for 1 year. He worked as the responsible physician of the adult bone marrow transplant unit at Liv Hospital Gaziantep Hospital for some time. He received the title of associate professor in March 2022.
Read moreAssoc. Prof. Ali Eser received his medical education at Uludağ University Faculty of Medicine; He completed his internal medicine residency training at Istanbul Training and Research Hospital and his hematology residency training at Marmara University.
Afterward, he completed his compulsory service at Marmara University Hematology Clinic, firstly at Çanakkale University and then at Bezmialem Vakıf University. He served as a lecturer. After working as a hematology specialist and assistant physician in charge of the adult bone marrow transplant unit for 2 years at Hisar Intercontinental Hospital, he worked as a lecturer at Bezmialem Vakıf University and in the adult bone marrow transplant unit at Istanbul Yeniyüzyıl University, and finally for 1 year. He worked as the responsible physician of the adult bone marrow transplant unit at Liv Hospital Gaziantep Hospital for some time. He received the title of associate professor in March 2022.
| Doctor's visit | price on request |
| Whipple surgery | $14500 - $15000 |
| Chemotherapy | $1500 - $2500 |
| Thyroid resection | $5000 - $7500 |
1- SSI Tepecik Hospital Pediatric Oncology Clinic (1990)
2- SSI Tepecik Hospital Pediatric Bone Marrow Transplantation Unit (1992)
3- EU Faculty of Medicine Pediatric Bone Marrow Transplantation Unit (1998)
4- FOUNDER of JOURNAL OF PEDIATRIC RESEARCH, 2014; SCI application was made in 2022.
1. İzmir BUÇH EAH Pediatric Bone Marrow Transplantation Unit (2019)
2. Ümraniye EAH Pediatric Bone Marrow Transplantation Unit (2020)
3. Kanuni Sultan Süleyman EAH Pediatric Bone Marrow Transplantation Unit (2020) (Transferred to Çam Sakura EAH)
Kansoy S. "Bone Marrow and Stem Cell Transplantation Child Health and Diseases, 1st edition, EU Faculty of Medicine Printing House, 1999, İzmir
Kansoy S. Bone marrow transplantation in Thalassemia Major III. Aegean Thalassemia Days Book, 2000, Izmir
Kansoy S. Pediatric KIT Center Standards in Turkey. Childhood Acute Leukemias, Antalya 2000: 73-5
Kansoy S. Late Side Effects in Children. Special issue of Bone Marrow Transplantation Journal of Turkish Clinics. 2003
Kansoy S. Stem Cell Applications in Bone Marrow and Stem Cell Transplantation. Pediatric Oncology Nursing Course Book, İzmir, 2005
Kansoy S. Cord Blood as a Stem Cell Source. Stem Cell Special Issue. Turkey Clinics, 2008
Kansoy S. Stem Cell Transplantation in Lymphomas. General Pediatrics Book, Ed. Prof.Dr.Enver Hasanoglu, 2009
Kansoy S, Aksoylar S. Bone Marrow Transplantation in Children. Pediatrics, 2014 and 2017
Kansoy S. Rhabdomyosarcoma. Pediatrics, 2014 and 2017
Kansoy S. Approach to the child with cancer according to clinical findings. Pediatrics, 2014 and 2017
11. Çetingül N, S.Kansoy, M.Kantar. Oncological Diseases. Pediatrics (Ed. A. Cura), 641-672, Ege University Print house, İzmir, 1999. (1.05 points)
Kansoy S, M.Kantar. Head, Face and Eye Examination. Pediatric Prosthetic Physical Examination and Symptom Information (Ed. A.Cura)
Kantar M. Metabolic Emergency Problems in Oncology. Oncologic Emergencies and Supportive Care in Childhood (Ed. N. Çetingül, S. Kansoy), 15-24, Meta Basım, İzmir, 2003.
Cord Blood Transplants in Turkey. HEMATOLOGIST, 2016
Kansoy S. Central Nervous System Tumors in Children Pediatrics, 2014 and 2017
Acute myeloblastic leukemia in children and its treatment. Pediatric Oncology Textbook, Poplack's Turkish, 2020
National pediatric stem cell transplant activity, 2020
Childhood stem cell transplantation indications, Turkey Clinics - International book 2020
In addition to the studies and papers in international journals published in large numbers, he is involved in international multicenter studies in some journals with high impact value.
Read more1- SSI Tepecik Hospital Pediatric Oncology Clinic (1990)
2- SSI Tepecik Hospital Pediatric Bone Marrow Transplantation Unit (1992)
3- EU Faculty of Medicine Pediatric Bone Marrow Transplantation Unit (1998)
4- FOUNDER of JOURNAL OF PEDIATRIC RESEARCH, 2014; SCI application was made in 2022.
1. İzmir BUÇH EAH Pediatric Bone Marrow Transplantation Unit (2019)
2. Ümraniye EAH Pediatric Bone Marrow Transplantation Unit (2020)
3. Kanuni Sultan Süleyman EAH Pediatric Bone Marrow Transplantation Unit (2020) (Transferred to Çam Sakura EAH)
Kansoy S. "Bone Marrow and Stem Cell Transplantation Child Health and Diseases, 1st edition, EU Faculty of Medicine Printing House, 1999, İzmir
Kansoy S. Bone marrow transplantation in Thalassemia Major III. Aegean Thalassemia Days Book, 2000, Izmir
Kansoy S. Pediatric KIT Center Standards in Turkey. Childhood Acute Leukemias, Antalya 2000: 73-5
Kansoy S. Late Side Effects in Children. Special issue of Bone Marrow Transplantation Journal of Turkish Clinics. 2003
Kansoy S. Stem Cell Applications in Bone Marrow and Stem Cell Transplantation. Pediatric Oncology Nursing Course Book, İzmir, 2005
Kansoy S. Cord Blood as a Stem Cell Source. Stem Cell Special Issue. Turkey Clinics, 2008
Kansoy S. Stem Cell Transplantation in Lymphomas. General Pediatrics Book, Ed. Prof.Dr.Enver Hasanoglu, 2009
Kansoy S, Aksoylar S. Bone Marrow Transplantation in Children. Pediatrics, 2014 and 2017
Kansoy S. Rhabdomyosarcoma. Pediatrics, 2014 and 2017
Kansoy S. Approach to the child with cancer according to clinical findings. Pediatrics, 2014 and 2017
11. Çetingül N, S.Kansoy, M.Kantar. Oncological Diseases. Pediatrics (Ed. A. Cura), 641-672, Ege University Print house, İzmir, 1999. (1.05 points)
Kansoy S, M.Kantar. Head, Face and Eye Examination. Pediatric Prosthetic Physical Examination and Symptom Information (Ed. A.Cura)
Kantar M. Metabolic Emergency Problems in Oncology. Oncologic Emergencies and Supportive Care in Childhood (Ed. N. Çetingül, S. Kansoy), 15-24, Meta Basım, İzmir, 2003.
Cord Blood Transplants in Turkey. HEMATOLOGIST, 2016
Kansoy S. Central Nervous System Tumors in Children Pediatrics, 2014 and 2017
Acute myeloblastic leukemia in children and its treatment. Pediatric Oncology Textbook, Poplack's Turkish, 2020
National pediatric stem cell transplant activity, 2020
Childhood stem cell transplantation indications, Turkey Clinics - International book 2020
In addition to the studies and papers in international journals published in large numbers, he is involved in international multicenter studies in some journals with high impact value.
| Doctor's visit | price on request |
| Bone marrow transplantation | $35000 - $75000 |
| Immunotherapy | $3420 - $9000 |
| Radiotherapy for cervical cancer | $8000 - $15000 |
| Doctor's visit | price on request |
| Radiofrequency ablation | $6000 |
| Lung cancer surgery | $10300 - $16400 |
| Allogenic bone marrow transplantation from an unrelated donor | $110000 |
Education
Career
Education
Career
PROFESSIONAL EXPERIENCE
2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine
2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine
06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine
10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship
2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship
2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist
2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.
EDUCATION
2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey
2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey
2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey
2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey
2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.
2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey
INTERNATIONAL CLINICAL TRIALS:
1. Astefania - ROCHE
2. PFİZER
3. RECITE - AMGEN
4. NAVIGATE - BAYER
5. RUBY - Tesaro (PRA)
6. ENGOT-ov43/GOG-3036 - MSD
7. ASTRA ZENECA
8. ROSY-O - ASTRA ZENECA
INTERNATIONAL PUBLICATIONS
I. Published journal articles indexed by SCI, SSCI, and AHCI
Weekly Paclitaxel in Classic Kaposi Sarcoma
Carboplatin Desensitization in Ovarian Carcinoma
High-Dose Chemotherapy for Ewing’s Sarcoma
Multidrug Refractory TFE3(+) Renal Cell Carcinoma
Crizotinib Efficacy in NSCLC with MET Alterations
Clinicopathological Features in ALK Mutant NSCLC
PSMA-Based Tumor Burden in Prostate Cancer
Atezolizumab in Metastatic Urothelial Carcinoma
Pulmonary Sarcomatoid Carcinoma
Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma
Atezolizumab with Chemotherapy in Small Cell Lung Cancer
FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer
Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients
Real-Life Efficacy of Osimertinib in Advanced NSCLC
ALK-Positive Cells Percentage and Alectinib Efficacy
Real-World Data on Alectinib in ALK-Positive NSCLC
Prognostic Factors in Metastatic RCC with T790M Mutation
FLOT Regimen in Metastatic Gastric Cancer
Desensitization Protocol in Lenalidomide Hypersensitivity Reactions
Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity
Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors
Subsequent Treatments in Hormone-Positive Breast Cancer Progression
Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer
Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer
Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer
Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer
Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients
Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients
Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases
FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer
Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer
Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma
Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma
Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)
Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)
Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.
Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49
Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4
Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.
Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology
Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)
Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)
Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)
Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)
Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye
Thesis:
Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)
International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)
Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination
Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study
Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer
Efficacy of temozolomide in pretreated patients with metastatic sarcoma
Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors
Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma
Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases
Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma
Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study
Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences
Read more
PROFESSIONAL EXPERIENCE
2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine
2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine
06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine
10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship
2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship
2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist
2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.
EDUCATION
2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey
2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey
2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey
2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey
2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.
2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey
INTERNATIONAL CLINICAL TRIALS:
1. Astefania - ROCHE
2. PFİZER
3. RECITE - AMGEN
4. NAVIGATE - BAYER
5. RUBY - Tesaro (PRA)
6. ENGOT-ov43/GOG-3036 - MSD
7. ASTRA ZENECA
8. ROSY-O - ASTRA ZENECA
INTERNATIONAL PUBLICATIONS
I. Published journal articles indexed by SCI, SSCI, and AHCI
Weekly Paclitaxel in Classic Kaposi Sarcoma
Carboplatin Desensitization in Ovarian Carcinoma
High-Dose Chemotherapy for Ewing’s Sarcoma
Multidrug Refractory TFE3(+) Renal Cell Carcinoma
Crizotinib Efficacy in NSCLC with MET Alterations
Clinicopathological Features in ALK Mutant NSCLC
PSMA-Based Tumor Burden in Prostate Cancer
Atezolizumab in Metastatic Urothelial Carcinoma
Pulmonary Sarcomatoid Carcinoma
Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma
Atezolizumab with Chemotherapy in Small Cell Lung Cancer
FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer
Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients
Real-Life Efficacy of Osimertinib in Advanced NSCLC
ALK-Positive Cells Percentage and Alectinib Efficacy
Real-World Data on Alectinib in ALK-Positive NSCLC
Prognostic Factors in Metastatic RCC with T790M Mutation
FLOT Regimen in Metastatic Gastric Cancer
Desensitization Protocol in Lenalidomide Hypersensitivity Reactions
Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity
Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors
Subsequent Treatments in Hormone-Positive Breast Cancer Progression
Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer
Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer
Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer
Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer
Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients
Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients
Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases
FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer
Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer
Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma
Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma
Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)
Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)
Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.
Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49
Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4
Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.
Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology
Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)
Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)
Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)
Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)
Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye
Thesis:
Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)
International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)
Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination
Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study
Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer
Efficacy of temozolomide in pretreated patients with metastatic sarcoma
Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors
Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma
Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases
Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma
Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study
Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences
| Doctor's visit | price on request |
| Radioiodine therapy | $5000 - $7000 |
| Radiation therapy for brain tumor | $4000 - $6000 |
| Mastectomy | $5000 - $7500 |
| Doctor's visit | price on request |
| Radiofrequency ablation | $6000 |
| Lung cancer surgery | $10300 - $16400 |
| Allogenic bone marrow transplantation from an unrelated donor | $110000 |
Dr. has a medical diploma from Uludağ University Medical College, Bursa, Turkey (1983), post-doctoral fellowship in Thermoradiotherapy from Thomas Jefferson University, Philadelphia, PA (1990-1994), and residency in Radiation Oncology from Center of Oncology & Nuclear Medicine, Istanbul, Turkey (1990). He has also held positions as professor, chairman, and faculty accreditation coordinator at Uludağ University Medical College (1991-2005), professor and director at Anadolu Medical Center (2004-2017), and director at Ceylan International Hospital and Medicana Bursa Hospital (2017-present).
Read moreDr. has a medical diploma from Uludağ University Medical College, Bursa, Turkey (1983), post-doctoral fellowship in Thermoradiotherapy from Thomas Jefferson University, Philadelphia, PA (1990-1994), and residency in Radiation Oncology from Center of Oncology & Nuclear Medicine, Istanbul, Turkey (1990). He has also held positions as professor, chairman, and faculty accreditation coordinator at Uludağ University Medical College (1991-2005), professor and director at Anadolu Medical Center (2004-2017), and director at Ceylan International Hospital and Medicana Bursa Hospital (2017-present).
Prof. Dr. Serdar Bedii Omay graduated from Hacettepe Medical School in 1985 and later specialized in Internal Medicine and Hematology. He has published 65 scientific articles, 112 meeting papers, and 34 conference presentations in the field of Hematology and Bone Marrow Transplantation. He has also worked as a Hematology Specialist and Molecular Hematology Doctor at Japan Mie Medical Faculty in 1995.
Read moreProf. Dr. Serdar Bedii Omay graduated from Hacettepe Medical School in 1985 and later specialized in Internal Medicine and Hematology. He has published 65 scientific articles, 112 meeting papers, and 34 conference presentations in the field of Hematology and Bone Marrow Transplantation. He has also worked as a Hematology Specialist and Molecular Hematology Doctor at Japan Mie Medical Faculty in 1995.
| Doctor's visit | price on request |
| Bone marrow transplantation | $39000 - $125000 |
| Stomach cancer surgery | $14500 - $20000 |
| Pancreatic cancer surgery | $9000 - $13000 |